View Full Company Profile

rYojbaba Co., Ltd.

CIK: 2012600 Filed: March 23, 2026 20-F

Key Highlights

  • Strategic growth through key acquisitions, expanding into HR technology and strengthening health services.
  • Nasdaq listing provides access to a major global market and boosts visibility.
  • Stock splits in 2021 and 2024 aim to increase share affordability and investor appeal.
  • Diversified operations include labor consulting, osteopathic clinics, and beauty salons.

Financial Analysis

rYojbaba Co., Ltd. Annual Report - How They Did This Year

Hey there! Thinking about investing in rYojbaba Co., Ltd.? This guide helps you understand what they do. It also shows how they've been doing lately and what might come next. We'll break down their annual report into easy-to-digest pieces. It's like we're chatting over coffee. No fancy finance talk, just what you need to know to make an informed decision.

  1. What does this company do and how did they perform this year? rYojbaba Co., Ltd. is a Japanese company. They operate in a few key areas. They offer Consulting Services, mainly labor consulting. This means they advise businesses on human resources and employment. They also have a big presence in Health Services. They run Osteopathic Clinics and Beauty Salons. These offer treatments like judo therapy and acupuncture. Beyond these, their Corporate and Support team manages overall operations. They provide administrative and strategic guidance for the whole group.

    This past year, they grew their business through smart acquisitions. In 2023, they bought Global HR Technology Co. Ltd. This expands them into HR technology. It also complements their labor consulting services. They also bought Sakai Seikotsuin Nish Co. Ltd. in 2022. In 2023, they acquired Great Shine Enterprises Ltd. These moves strengthen their health services and related areas. Sakai Seikotsuin Nish seems to be an osteopathic clinic chain. It directly expands their main health services. These actions show they are actively expanding. They focus on their core and complementary businesses.

  2. Financial performance - revenue, profit, growth metrics The company clearly focuses on growth through acquisitions. They bought Global HR Technology Co. Ltd. in 2023. They also acquired Sakai Seikotsuin Nish Co. Ltd. in 2022 and Great Shine Enterprises Ltd. in 2023. About 40% of their osteopathic clinic income for the year ending December 31, 2025, came from health insurance payments. This shows they rely heavily on Japan's healthcare payment system for some income. They also employ many specialized staff. As of December 31, 2025, 72.4% of their 123 full-time clinic staff are judo therapists. Another 11.4% are acupuncture therapists. This highlights the size of their health services.

  3. Major wins and challenges this year Major Wins:

    • Strategic Acquisitions: rYojbaba actively expanded by buying companies. These include Global HR Technology Co. Ltd. (2023), Sakai Seikotsuin Nish Co. Ltd. (2022), and Great Shine Enterprises Ltd. (2023). This shows a clear growth strategy. They are diversifying into HR technology and strengthening health services.
    • Stock Splits: The company split its stock twice. Once in October 2021, and again in March 2024. Stock splits make shares more affordable. This can attract more investors. It also makes shares easier to trade.
    • Nasdaq Listing: rYojbaba's shares trade on Nasdaq. This is a big achievement for a Japanese company. It gives them access to a major global market. It also boosts their visibility and ability to raise money.

    Challenges:

    • Integrating Acquisitions: The company is integrating new businesses. This can be complex and costly. It might also lead to unexpected problems and expenses.
    • Navigating Intense Competition: rYojbaba faces tough competition. This is true for its osteopathic clinics (especially in Fukuoka) and labor consulting. They must work hard to keep market share. They also need to attract customers and talented staff.
    • Managing Geographic Concentration Risk: Most of their clinics are in one area. As of December 31, 2025, 97% of their clinics are in Japan's Kyusyu area. 69% are in Fukuoka Prefecture. This makes them vulnerable to local economic problems or natural disasters.
    • Adapting to Regulatory Changes and Compliance Costs: The company faces ongoing challenges with complex Japanese laws. These include healthcare and labor laws. Being a U.S.-listed company also adds regulatory costs.
    • Addressing Labor Shortages and Rising Costs: Finding and keeping qualified staff is hard. Especially judo and acupuncture therapists. Labor shortages and rising costs could impact their expenses and profits.
    • Uncertainty Around Reimbursement Policies: About 40% of clinic income comes from health insurance. Changes in payment policies from the government or insurers could hurt their financial stability.
    • Potential for Negative Publicity and Brand Damage: As a service business, they must protect their brand reputation. This is especially true with many clinics in one area. Future franchising also adds risk. Problems at one location could harm the whole brand.
  4. Financial health - cash, debt, liquidity The company may need to raise more money later. This would fund growth, acquisitions, and operations. This suggests current cash might not cover all planned expansions. Also, a new accounting rule is coming. It will require companies to list operating leases, like clinic rent, as debts on their balance sheet. This means rYojbaba has lease debts not yet shown. These will soon affect their reported debt. This could change how investors see their financial health.

  5. Key risks that could hurt the stock price Investing in rYojbaba has high risks. The company operates in fast-changing industries. Here are key things that could go wrong and affect your investment:

    General Company Risks:

    • Need for More Money: The company might need to raise more money. This would fund growth plans. For example, new opportunities, acquisitions, infrastructure, hiring, or dealing with competition and rules. They might issue new shares. This could mean more shares issued, reducing your ownership percentage. Raising money can be costly or hard. If they can't get it, they might slow growth. They might even cut back on current businesses.
    • Potential for More Shares Issued from Stock Acquisition Rights: HeartCore has a special right to buy many rYojbaba shares. The price is very low: $0.01 per share. This right became active when rYojbaba listed on Nasdaq. HeartCore can buy shares equal to about 3% of all rYojbaba's shares at the listing time. When HeartCore buys these shares, it increases the total shares available. This means your shares will represent a smaller part of the company. This is called more shares issued, reducing your ownership percentage. This is a pre-arranged deal. Be aware it can impact your ownership value.
    • Tax Complications for U.S. Investors (PFIC Risk): The company might be called a "Passive Foreign Investment Company" (PFIC) for U.S. taxes. This happens if 50% or more of their assets create passive income. Or if 75% or more of their total income is passive. If this happens, U.S. shareholders could face complicated, unfavorable taxes. The company believes it was not a PFIC in 2024. But this status can change. It depends on IPO cash and goodwill value. U.S. investors should assume they cannot make a special tax election (QEF). This election could lessen negative impacts.
    • Difficulty Suing the Company/Directors in U.S. Courts: It might be hard for investors to sue the company or its directors in U.S. courts. (Except for one specific director.) It's also hard to enforce U.S. judgments. This is because they are based in Japan. Japanese shareholder rights might differ from other countries. For example, only shareholders with 3% or more voting rights can check company accounting books. Also, it's unclear how directors would handle an unsolicited takeover bid. This differs from other countries.
    • Litigation Risks from Operations: Beyond general legal issues, the company faces many lawsuit risks daily. For labor consulting, clients could sue them for damages. This happens if advice is wrong, misleading, or incomplete. They also risk lawsuits if they advise on illegal labor practices. Or if they facilitate them, or breach a contract. Misusing or leaking client confidential information could also lead to lawsuits. In osteopathic clinics, patients could sue. This happens if they are unhappy with results. Or if they claim malpractice or a medical error. Disputes might also arise over treatment or services. Especially if a patient is injured or an accident happens during therapy. Such lawsuits can be costly. They can damage reputation and distract management. Also, employees (or future franchisee employees) could sue the company. They might claim discrimination, harassment, or unfair dismissal. Or other labor law violations. Such claims, even if false, can lead to high legal costs. They can also mean settlement payments. This damages their brand and makes it hard to keep good employees. This distracts management and can hurt their financial health.
    • International Expansion, Economic Swings & Currency Risks: Most of their money comes from Japan. But they want to expand clinics into new Japanese regions. They also eye overseas markets like the U.S. and Southeast Asia. This expansion, plus their current international presence, means currency changes could affect them. Their main currency is the Japanese Yen. They report in U.S. Dollars. If the Yen changes value much against other currencies, it could impact their financial results. They do not currently protect themselves from these currency swings. Expanding abroad brings many other risks. These include political issues (terrorism, war) and supply chain problems. They might struggle to get supplies. Sanctions could affect them. Governments might take over assets. New tariffs or trade barriers could arise. Inflation or deflation is possible. Currency controls could change suddenly. They might not follow foreign laws. Data privacy and cybersecurity laws vary. Unfair trade policies could hurt them. Enforcing contracts or collecting payments might be hard. Setting up controls across diverse operations is challenging. Beyond currency, their financial health could suffer. General economic conditions and markets in Japan and other countries affect them. A Japanese economic downturn, for example, could mean lower sales. This might force them to slow growth plans. They could also face labor shortages in Japan or other markets.
    • Natural Disasters & Global Events: Like many businesses, rYojbaba is vulnerable to disruptions. These include natural disasters, epidemics (like pandemics), political events, war, or terrorism. These events, plus economic downturns, inflation, or rising interest rates, could hurt them. They could mean lower sales, higher costs, more spending. They could also disrupt their workforce.
    • Less U.S. Investor Protection: As a "foreign private issuer," rYojbaba can follow Japanese rules. This means they skip some U.S. SEC and Nasdaq requirements. This might mean less protection for U.S. investors. A purely U.S. company offers more. For example, they don't need a separate committee for executive pay. They also don't need one for director nominations. U.S. companies usually have these. They file reports less often and slower than U.S. companies. They can also give less detail on executive pay. (They might show total pay for all top executives, not individual breakdowns.) Plus, rules like Regulation FD, which ensure all investors get information at the same time, do not apply to them. Also, CEO Ryoji Baba controls about 69.47% of the voting power. This makes the company a "controlled company." This lets them skip even more Nasdaq governance rules. Specifically, their board does not need mostly independent members. They also don't need independent committees for pay or nominations. Their shareholder meetings also have different quorum rules. This high voting power means management has the final say. This includes electing directors, mergers, acquisitions, and selling major assets. They can even change company documents. Actions other shareholders favor might be delayed or stopped. Management's interests might not always align with yours. It could also make a takeover of rYojbaba very difficult. This might prevent shareholders from getting a premium price for their shares. Management might also choose paths that benefit them. These paths could be riskier for other shareholders. As a U.S. investor, you might not have the same protections. Shareholders in other U.S.-listed companies have more.
    • Less Independent Scrutiny on Financial Controls (as an "Emerging Growth Company"): rYojbaba is an "emerging growth company." This special status lets them follow fewer reporting rules. Bigger, established public companies have more rules. One key difference: their independent auditors do not confirm internal financial controls. (These are systems and checks to ensure money is counted and reported correctly.) Management will state if controls are effective. They will also report changes. But auditors do not provide the same independent check as for larger companies. This means problems with financial reporting might not be caught early. If internal control issues are found later, or when auditors do check, problems could arise. This could mean reporting delays, regulator penalties, lost investor trust, and a stock price drop. Fixing these issues could also cost much money and management time.
    • Risks from Acquisitions: The company's strategy includes buying other businesses. These deals can be time-consuming, difficult, and expensive. Integrating new companies can bring unexpected problems and costs. They might not get the expected benefits. They also risk taking on unknown legal issues or debts from acquired companies. Acquisitions can distract management. They can also mean more shares issued, reducing your ownership percentage if new shares pay for them. Specifically, growing by hiring consultants or buying other firms has risks. They might struggle to find and keep new consultants. Integrating them could distract management. It could also cause client problems or conflicts of interest. It might require much more money. Costs could rise to improve systems and coordinate. Blending different work cultures could be hard. If they fail to manage these efforts, their competition ability could suffer. Also, if acquisition benefits don't meet expectations, the stock price could drop. This can happen even before the deal closes.
    • Geographic Concentration of Clinics: Most of their business is in one area. As of December 31, 2025, 97% of their clinics and salons are in Japan's Kyusyu area. Even more, about 69% are in Fukuoka Prefecture. If anything bad happens in Kyusyu or Fukuoka, it could hit their business hard. This includes natural disasters, local economic problems, or regulation changes. A company spread out would be less affected. Fukuoka is very competitive for osteopathic clinics. In 2022, it ranked in Japan's top 10 for clinic numbers. More competitors could appear and take market share. Osteopathic clinics are relatively cheap to start.
    • General Competition: rYojbaba faces strong competition in all its services. This includes more than just consulting. Both osteopathic clinics and labor consulting are very competitive markets. For clinics, competition depends on price, convenience, service quality, brand, and location. If rYojbaba's clinics can't compete well, they could lose customers. Their income could drop. They also compete for good locations and qualified staff, like judo therapists. In labor consulting, they compete with other firms. New technologies offering automated solutions also compete. Some competitors might have more money or stronger brands. They might also be more established where rYojbaba operates or plans to. All these factors could hurt their business and finances.
    • Negative Publicity, Brand Damage, and Employee Claims: rYojbaba's success depends on strong, trusted brands. Even small incidents could seriously damage their brand. This is especially true with negative social media attention or lawsuits. This could include issues with future franchisees. It could also be security breaches or employee actions. The company screens staff. But they cannot guarantee staff or customers will not act illegally or inappropriately. Such actions could harm their brand or others' well-being. Negative publicity, even if false, can hurt. This risk is high because clinics are concentrated geographically. A problem at one clinic could affect many others. It's also a big concern for future franchised clinics. rYojbaba has limited control over their daily operations. Bad press from a franchisee could still damage the entire brand. The medical industry faces scrutiny from "fringe" businesses. This could cast a shadow on legitimate operators like rYojbaba.
    • Regulatory Compliance and Changing Laws: Japanese laws regulate their osteopathic and beauty salon services. These include judo therapy and acupuncture. Japan's healthcare industry is heavily regulated. They also follow complex labor laws and standards. Changes or new laws can affect their operations. For example, Japanese labor laws govern employee relationships. They cover employment types (employee, contractor) and minimum wage. They also cover employer contributions to social security, unemployment, and accident compensation. Big changes to these laws could impact costs and finances. This includes higher minimum wages or altered employment status rules. Also, if their employees or future franchisee employees unionize, it could affect their business and finances. In osteopathic clinics, many changes could affect them. These include licensing systems and judo therapist qualifications. Insurance systems, medical billing, and data privacy laws (like PIPL) also apply. If rYojbaba fails to understand or follow these complex laws, they could face penalties. They might also need big operational changes. Or they could suffer bad publicity. Failing to manage legal risks and violations can severely damage their reputation and credibility. They might also face burdensome requirements. These include registering as an investment company or adopting specific corporate structures. Increased reporting, record-keeping, and disclosure rules also apply.
    • Changes in Payment Policies: About 40% of rYojbaba's osteopathic clinic income for the year ending December 31, 2025, came from health insurance payments. Their treatments depend on what government and private insurers cover. It also depends on how much they pay. These policies directly affect customer service choices and prices. Even with a promising new service, demand might be low. This is true unless it gets proper payment approval. Any future Japanese changes could reduce service payments. This could greatly harm their business, financial health, and operating results.
    • Protecting Their Intellectual Property: The company relies on its trademarks, trade secrets, and know-how. (This includes training methods.) As of December 31, 2025, they only have 12 trademarks registered in Japan. They have none in other countries. If they can't protect these in Japan, or if someone infringes elsewhere, it could hurt their brand. It could also hurt their growth.
    • Labor Shortages and Costs in Clinics: Running clinics and salons relies heavily on staff. Especially specialized roles like judo therapists (72.4% of 123 full-time clinic staff as of Dec 31, 2025) and acupuncture therapists (11.4%). If they or franchisees face staff shortages, costs could rise. Higher labor costs from competition, minimum wages, or benefits also increase costs. They might not pass these costs to customers through price increases. This would squeeze their profit margins. High employee turnover in clinics is common. This could make growth harder and increase costs.
    • Contracts with Minor Customers: In Japan, people under 18 are minors. They generally cannot sign contracts without parent permission. rYojbaba tries to get parental consent for treatments. But if a parent disagrees, the contract can be canceled. This could lead to lost income or complications.
    • Broader Market and Industry Trends: Your investment could also be affected by broader market and industry trends. This is true even if rYojbaba performs well. Sometimes, the stock market or an industry (like retail or services) has ups and downs. These are not directly related to a company's performance. If investors lose confidence in the market or similar companies, their stock price could drop. This could also make it harder for rYojbaba to raise more money later.
    • Changes to Accounting Rules: Company financial reporting rules can change. New accounting rules could affect how rYojbaba shows its financial health. For example, a new rule will soon require companies to show operating leases. (Like clinic rent.) These will be debts on their balance sheet. This means their balance sheet might look different. It could show more debt. This might change how investors see their financial stability.
    • Increased Costs as a Public Company: As a public company, rYojbaba faces much higher costs. These include legal advice, accounting, and following all rules (compliance). Management will also spend more time on these new responsibilities. This could take away from growing the business.

    Risks Related to Future Franchise Operations:

    • Dependence on Future Franchisee Success: As of December 31, 2025, rYojbaba has no franchised clinics. But they plan to have them. They expect to earn money from royalty fees. Their financial results will depend on future franchisee performance. If franchisees struggle financially, it could hurt rYojbaba's income. This includes inability to get loans or economic downturns. If many franchisees face financial trouble, rYojbaba's royalty money could drop much. The negative impact on overall profit could be even bigger. This is because they might still have fixed costs to cover. If franchised clinics close, royalty income drops further. This could hurt profit margins.
    • Limited Control Over Franchisee Operations: rYojbaba will set standards and train. But franchisees are independent business owners. This means rYojbaba will have limited control over daily operations. If franchisees don't meet rYojbaba's standards, it could cause harm. Or if they don't hire and train qualified staff (like medical therapists). This could damage the company's image and reputation. It could also lead to lower sales across the franchise system. This would reduce rYojbaba's royalty income.
    • Enforcing Franchise Agreements Can Be Tricky: rYojbaba plans detailed franchise agreements. But these can be hard and costly to enforce. Disputes might arise over money, financing, or intellectual property. (Like trademarks or special training methods.) Enforcing their rights can be costly and unpredictable. Even with confidentiality agreements, risks exist. Trade secrets or know-how could be breached or unprotected. Competitors could also develop similar methods.
    • Financial Health of Franchisees is Key: rYojbaba will rely on future franchisees' financial health. If they don't monitor franchisees properly, problems can arise. If franchisees face financial hardship (like too much debt or market struggles), it could hurt rYojbaba's operations. This could happen through delayed payments or bankruptcies. Bankruptcies could also hurt rYojbaba's market share. It could make attracting new franchisees harder.
    • Early Terminations Can Hurt: Franchise agreements can end early. This happens if a franchisee fails to pay or abandons the business. If this happens, rYojbaba might sue for damages. This means significant legal fees. Money from damages might be much less. They would have earned more from the franchise over time. Plus, if rYojbaba is still responsible for the clinic's lease, they might pay rent. Or they might settle with the landlord. This could be a big unexpected cost. Many early terminations could really hurt their finances and growth plans.
    • Potential Conflicts and Legal Disputes: Franchisees are independent. Their goals might sometimes clash with rYojbaba's strategies. This could lead to disagreements and even lawsuits. Such disputes would distract management and cost money. They would also take resources from business growth. This is true even if rYojbaba wins the legal battle.
    • Japanese Regulations on Franchising: Japanese laws, like the Antimonopoly Act, apply to rYojbaba. These laws govern how they interact with franchisees. They must clearly explain all terms and conditions. They must also ensure income or profit estimates are based on facts. If the JFTC finds rule violations, they could face penalties. (For example, misleading potential franchisees.) They could get orders to stop activities. They might also remove contract clauses or face other penalties.

Risk Factors

  • Significant geographic concentration of clinics (97% in Kyusyu, 69% in Fukuoka) creates vulnerability to local issues.
  • Uncertainty around reimbursement policies, as 40% of clinic income relies on health insurance payments.
  • Potential for substantial dilution from HeartCore's stock acquisition rights at $0.01 per share.
  • Limited U.S. investor protection due to 'foreign private issuer' and 'controlled company' status, with CEO Ryoji Baba holding 69.47% voting power.
  • Challenges in integrating acquisitions and navigating intense competition in core markets.

Why This Matters

This annual report for rYojbaba Co., Ltd. is crucial for investors as it outlines a clear growth strategy centered on strategic acquisitions and market expansion. The company's Nasdaq listing signifies global ambition and access to broader capital, potentially enhancing its profile and liquidity. However, the report also highlights significant risks, such as heavy reliance on health insurance payments and a concentrated geographic footprint, which could impact financial stability. Understanding these dynamics is essential for assessing the company's future trajectory and investment potential.

Furthermore, the report details the company's operational structure, including its diverse services in labor consulting and health clinics, and its commitment to specialized staff. For investors, this provides insight into the business model's resilience and potential for diversification. The discussion of stock splits and potential future capital raises also informs investors about possible share dilution and the company's funding needs for its ambitious growth plans, making it a critical document for informed decision-making.

Finally, the transparency around governance, particularly the 'controlled company' status and limited U.S. investor protections, is a key takeaway. This information allows investors to weigh the benefits of growth against potential governance risks and the influence of the majority shareholder. It's a comprehensive look at both the opportunities and the inherent challenges of investing in a rapidly expanding, internationally listed Japanese company.

Financial Metrics

Osteopathic Clinic Income from Health Insurance ( Year Ending Dec 31, 2025) 40%
Full-time Clinic Staff ( As of Dec 31, 2025) 123
Judo Therapists Percentage of Clinic Staff ( As of Dec 31, 2025) 72.4%
Acupuncture Therapists Percentage of Clinic Staff ( As of Dec 31, 2025) 11.4%
Global H R Technology Co. Ltd. Acquisition Year 2023
Sakai Seikotsuin Nish Co. Ltd. Acquisition Year 2022
Great Shine Enterprises Ltd. Acquisition Year 2023
First Stock Split Year 2021
Second Stock Split Year 2024
Minimum Voting Rights for Accounting Books Check 3%
Heart Core Stock Acquisition Rights Percentage of Shares 3%
Heart Core Stock Acquisition Rights Price $0.01 per share
P F I C Status (2024) Not a PFIC
C E O Ryoji Baba Voting Power 69.47%
Clinics in Kyusyu Area ( As of Dec 31, 2025) 97%
Clinics in Fukuoka Prefecture ( As of Dec 31, 2025) 69%
Fukuoka Osteopathic Clinic Ranking (2022) Top 10 in Japan
Trademarks Registered in Japan ( As of Dec 31, 2025) 12
Minor Age in Japan 18

About This Analysis

AI-powered summary derived from the original SEC filing.

Document Information

Analysis Processed

March 24, 2026 at 03:46 PM

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.